You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ALLO Exercise Disclosure
Kazam Joshua A · SEC Form 4 · Filed Jun 23, 2026
Exercise
Calculated transaction value
$0
Kazam Joshua A Director
ALLO
Transaction date
Jun 18, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 5 days later
ALLO daily price context
Close on/before transaction
$2
Jun 18, 2026
First close after public filing
$2.05
Jun 24, 2026
30-day return after filing
-11.22%
Through Jul 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 47,700 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001221355-26-000002
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Allogene Therapeutics, Inc. ALLO Current | Exercise | Jun 18, 2026 | $0 |
| Allogene Therapeutics, Inc. ALLO | Exercise | Jun 18, 2026 | $0 |
| Allogene Therapeutics, Inc. ALLO | Award | Jun 18, 2026 | $0 |